ErtapenemThird Party Manufacturing in India

Ertapenem works by interfering with the construction of the bacterial cell wall, which causes the bacteria to rupture and die.

As a broad-spectrum carbapenem beta-lactam antibiotic, Ertapenem targets and binds to penicillin-binding proteins (PBPs), specifically PBP 2 and PBP 3, on the bacterial cell membrane. These proteins are enzymes responsible for the final transpeptidation step that cross-links peptidoglycan chains in the bacterial cell wall. By inhibiting these enzymes, Ertapenem prevents the synthesis of a stable cell wall. Without a protective outer wall to resist osmotic pressure, the bacterial cell swells and undergoes lysis.

Unlike penicillin or cephalosporin class antibiotics, Ertapenem is highly resistant to hydrolysis by most bacterial beta-lactamases, including extended-spectrum beta-lactamases (ESBLs). This makes it exceptionally effective against multi-drug resistant Gram-negative and Gram-positive pathogens, while its unique structure allows for once-daily dosing.

Ertapenem (CAS 153832-38-3) is a powerful carbapenem antibiotic used widely to combat moderate-to-severe bacterial infections. Celesta provides high-quality options for Ertapenem third party manufacturing in India, supplying domestic and international markets with sterile injectable formulations.

Therapeutic Uses

Ertapenem is prescribed for the treatment of:

• Complicated Intra-Abdominal Infections: Used to treat deep tissue abdominal infections caused by mixed aerobic and anaerobic pathogens.
• Complicated Skin and Soft Tissue Infections: Indicated for diabetic foot infections without osteomyelitis.
• Community-Acquired Pneumonia: Prescribed for severe lung infections requiring intravenous therapy.
• Complicated Urinary Tract Infections: Used for severe kidney and urinary tract infections, including pyelonephritis.
• Surgical Prophylaxis: Administered to prevent surgical site infections following elective colorectal surgery.

Choosing an Ertapenem Manufacturer in India

Ertapenem is a highly valued clinical antibiotic used in hospital settings for moderate-to-severe infections. Its once-daily dosing regimen offers a major commercial advantage over other carbapenems like meropenem or imipenem, which require multiple daily doses, making it a preferred choice for outpatient parenteral antimicrobial therapy (OPAT). For contract manufacturing, Ertapenem is an attractive premium product. Producing sterile carbapenem injectables requires dedicated beta-lactam manufacturing lines to avoid cross-contamination with non-beta-lactam drugs. Sourcing from a WHO-GMP certified manufacturer in India provides high-quality lyophilized powder for injection (500mg and 1g vials) complying with international standards, helping brands tap into institutional sales and government tenders.

To place an order or discuss customization, please contact our team. You can view our anti-infective portfolio on our manufacturing listing page or read about our capabilities on our contract manufacturing page.

This makes Ertapenem one of the most sought-after carbapenem antibiotics for third party manufacturing in India, with consistent demand from hospital supply chains and export markets.